Clinical Trial Update: Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating entinostat in combination with nivolumab and ipilimumab in previously treated renal cell carcinoma has been terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Entinostat (entinostat)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Roberto Pili | Conditions: Renal Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-09-03